Docoh
Loading...

ADPT Adaptive Biotechnologies

News

Pro users get this 30m faster
Cathie Wood's ARK Invest Posts Fund Purchases For Wednesday, Oct. 6, 2021: DNA, PATH, SGFY, PACB, BEAM, SSYS, TWOU, BLDE, VLD, NIU, MKFG,, ACHR, TDOC, SQ, VUZI, ADPT, SLGC, SURF, QSI, DYNS, PRNT
7 Oct 21
Hedge Funds, Trading Ideas, General
Ginkgo Bioworks (DNA) - 8,264,233 Shares UiPath (PATH) - 580,632 SIgnify Health (SGFY) - 325,861 Pacific Biosciences Of California (PACB) - 57,511 Beam Therapeutics (BEAM) - 93,625 Stratasys (SSYS) - 77,800 2U
Cathie Wood's ARK Invest Posts Fund Purchases For Tuesday, Oct. 5, 2021: TDOC, PACB, BEAM, SGFY, TWOU, DNA, SSYS, MKFG, ACHR, BLDE, VLD, NIU, SQ, VUZI, ADPT, SURF, QSI, SLGC, MASS, DYNS, PATH, HOOD, TOST, PRNT
6 Oct 21
Hedge Funds, Trading Ideas, General
Teladoc Health (TDOC) - 154,175 Shares Pacific Biosciences Of California (PACB) - 783,580 Beam Therapeutics (BEAM) - 104,491 Signify Health (SGFY) - 749,117 2U (TWOU) - 166,427 Gingko Bioworks (DNA) -
Adaptive Biotechnologies Launches Enhanced clonoSEQ Assay Reports For Patients With Chronic Lymphocytic Leukemia, Now Featuring IGHV Mutation Status
30 Sep 21
News
Adaptive Biotechnologies Corporation (NASDAQ:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease,
Adaptive Biotechnologies Sponsored Study Titled 'ImmuneSense COVID-19 Variant Study' Posted To ClinicalTrials.gov; Study Is Not Yet Recruiting
23 Sep 21
Biotech, News, FDA, General
https://clinicaltrials.gov/ct2/show/NCT05054088
Cathie Wood's ARK Invest Posts Fund Purchases For Friday, Sept. 10, 2021: VCYT, CRSP, SPFR, MKFG, RPTX, NVTA, PSNL, ADPT
13 Sep 21
Hedge Funds, Trading Ideas, General
Veracyte (VCYT) - 45,484 CRISPR Therapeutics (CRSP) - 17,000 Jaws Spitfire Acquisition Corp (SPFR) - 318482 Markforged Holding Corp (MKFG) - 174,225 Repare Therapeutics (RPTX)
Cathie Wood's ARK Invest Posts Fund Purchases For Thursday, Sept. 9, 2021: PATH, CRSP, PD, VCYT, AVAV, MKFG, SPFR, KMTUY, ROKU, SPLK, KVSB, NVTA, PSNL, ADPT, RPTX, HEI
10 Sep 21
Hedge Funds, Trading Ideas, General
UiPath (PATH) - 1,052,021 Shares Crispr Therapeutics (CRSP) - 36,990 PagerDuty (PD) - 76,000 Veracyte (VCYT) - 18,339 AeroVironment (AVAV) - 68,951 Markforged (MKFG) - 406,402 Jaws Spitfire Acquisitionn (SPFR) -
Cathie Wood's ARK Invest Posts Fund Purchases For Wednesday, Sept. 8, 2021: PATH, NVTA, FATE, PD, DE, MKFG, KMTUY, SPFR, ROKU, SPLK, KVSB, ADPT, SLGC, VCYT, PSNL, RPTX, ETSY, FTCH, STNE, Z, JD, HEI, BLDE, AVAV
9 Sep 21
Hedge Funds, Trading Ideas, General
UiPath (PATH) - 1,382,967 Shares Invitae (NVTA) - 616,413 Fate Therapeutics (FATE) - 129,739 PagerDuty (PD) - 55,058 Deere & Co (DE) - 37,991 Markforged (MKFG) - 600,664 Komatsu (KMTUY) - 96,118 Jaws
Cathie Wood's ARK Invest Posts Fund Purchases For Friday, Sept. 3, 2021: ROKU, FATE, BLDE, NIU, SPFR, GENI, PFE, RPTX, NVTA, PSNL, ADPT, JD, Z, MKFG
7 Sep 21
Hedge Funds, Trading Ideas, General
Roku (ROKU) - 128,864 Fate Therapeutics (FATE) - 237,809 Blade Air Mobility (BLDE) - 255081 Niu Technologies (NIU) - 4,712 Jaws Spitfire Acquisition Corp (SPFR) - 12,216 Genius
Cathie Wood's ARK Invest Posts Fund Purchases For Wednesday, Sept. 1, 2021: SGFY, FATE, KMTUY, ACIC, KTOS, KMFG, BLDE, SPFR, GENI, PFE, NVTA, RPTX, PSNL, ADPT, TDOC, Z, PRNT
2 Sep 21
Hedge Funds, Trading Ideas, General
Signify Health (SGFY) - 189,960 Shares Fate Therapeutics (FATE) - 1,075 Komatsu (KMTUY) - 175,000 Atlas Crest Investment (ACIC) - 144,000 Kratos Defense & Security Solutions (KTOS) - 41,408 Markforged (MKFG) -
Cathie Wood's ARK Invest Posts Fund Purchases For Tuesday, Aug. 31, 2021: ZM, VCYT, SGFY, KMTUY, NNDM, KTOS, DDD, NIU, MKFG, BLDE, GENI, FATE, PFE, RPTX, NVTA, PSNL, ADPT, HOOD, STNE, Z, TDOC
1 Sep 21
Hedge Funds, Trading Ideas, General
Zoom Video Communications (ZM) - 194,080 Shares Veracyte (VCYT) - 80,700 Signify Health (SGFY) - 92,717 Komatsu (KMTUY) - 279,686 Nano Dimension (NNDM) - 456,084 Kratos Defense & Security Solutions (KTOS) -
Cathie Wood's ARK Invest Posts Fund Purchases For Monday, Aug. 30, 2021: SGFY, FATE, VCYT, ACIC, DDD, NNDM, MKFG, KTOS, NIU, BLDE, SPFR, PTON, GENI, PFE, NVTA, DYNS, QSI, ADPT, PSNL, RPTX
31 Aug 21
Hedge Funds, Trading Ideas, General
Signify Health (SGFY) - 418,845 Fate Therapeutics (FATE) - 89,825 Veracyte (VCYT) - 3,391 Atlas Crest Investment Corp (ACIC) - 860,704 3D Systems (DDD) - 138,600 Nano Dimensions (NNDM)
Cathie Wood's ARK Invest Posts Fund Purchases For Friday, Aug. 27, 2021: FATE, SGFY, ACIC, KTOS, GENI, PFE, DYNS, RPTX, PSNL, ADPT, QSI, PDD, JD, TDOC, PRNT
30 Aug 21
Hedge Funds, Trading Ideas, General
Fate Therapeutics (FATE) - 172,458 Signify Health (SGFY) - 190,400 Atlas Crest Investment Corp (ACIC) - 190,900 Kratos Defense & Security Solutions (KTOS) - 59,400 Genius Sports
Cathie Wood's ARK Invest Posts Fund Purchases For Thursday, Aug. 26, 2021: NVTA, SGFY, FATE, VCYT, KTOS, ACIC, AVAV, KMTUY, SPLK, GENI, LPSN, PFE, ADPT, BEAM, MASS, PSNL, QSI, CMIIU, RPTX, DYNS, PDD, COIN, PRNT
27 Aug 21
Hedge Funds, Trading Ideas, General
Invitae (NVTA) - 319,045 Shares Signify Health (SGFY) - 178,955 Fate Therapeutics (FATE) - 60,075 Veracyte (VCYT) - 26,653 Kratos Defense & Security Solutions (KTOS) - 201,508 Atlas Crest Investment (ACIC) -
Cathie Wood's ARK Invest Posts Fund Purchases For Wednesday, Aug. 25, 2021: SGFY, NVTA, FATE, KMTUY, DDD, MKFG, AVAV, KTOS, GENI, LPSN, PFE, QSI, ADPT, PSNL, MASS, CMIIU, DYNS, COIN, TCEHY, TDOC, PDD, JD, Z, ACIC, PRNT
26 Aug 21
Hedge Funds, Trading Ideas, General
Signify Health (SGFY) - 206,099 Shares Invitae (NVTA) - 113,774 Fate Therapeutics (FATE) - 1,000 Komatsu (KMTUY) - 96,487 3D Systems (DDD) - 64,660 Markforged (MKFG) - 383,005 AeroVironment (AVAV) - 3,059 Kratos
Cathie Wood's ARK Invest Posts Fund Purchases For Tuesday, Aug. 24, 2021: DKNG, FATE, SRNG, SGFY, NVTA, KTOS, MKFG, DDD, KMTUY, SPFR, GENI, LPSN, PFE, ADPT, QSI, PSNL, MASS, CMIIU, RPTX, DYNS, Z, TDOC, COIN, PDD, PRNT, ACIC
25 Aug 21
Hedge Funds, Trading Ideas, General
DraftKings (DKNG) - 1,073,171 Shares Fate Therapeutics (FATE) - 529,348 Soaring Eagle Acquisition (SRNG) - 1,197,532 Signify Health (SGFY) - 205,551 Invitae (NVTA) - 49,322 Kratos Defense & Security
Return on Capital Employed Insights for Adaptive Biotechnologies
20 Aug 21
Earnings
After pulling data from Benzinga Pro it seems like during Q2, Adaptive Biotechnologies (NASDAQ:ADPT) brought in sales totaling $38.51 million. However, earnings decreased 20.55%, resulting in a loss of $49.77 million.
The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck
19 Aug 21
Biotech, News, Penny Stocks, Health Care, Small Cap, FDA, General
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 18)
Stocks That Hit 52-Week Lows On Wednesday
18 Aug 21
News, Intraday Update, Markets, Movers, Trading Ideas
Wednesday morning, 136 companies reached new 52-week lows.
The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline
18 Aug 21
Biotech, Earnings, News, Penny Stocks, Small Cap, FDA, Top Stories, General
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17)
Stocks That Hit 52-Week Lows On Tuesday
17 Aug 21
News, Intraday Update, Markets, Movers, Trading Ideas
Tuesday morning, 282 companies set new 52-week lows.

Press releases

Pro users get this 30m faster
Adaptive Biotechnologies to Report Third Quarter Financial Results on November 3, 2021
6 Oct 21
News, Press Releases
SEATTLE, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (NASDAQ:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical
Adaptive Biotechnologies Presents New Data During IDWeek Demonstrating the Capability of Its Immune Medicine Platform to Distinguish Between SARS-CoV-2 Infection and Vaccine Response and Detect Lyme Disease
2 Oct 21
Health Care, Analyst Ratings, Press Releases
Real-world data show T-Detect™ COVID can detect prior SARS-CoV-2 infection nearly 12 months after initial diagnosis in some patients New research demonstrates T-cell testing using T-cell receptor (TCR)
Adaptive Biotechnologies Launches Enhanced clonoSEQ® Assay Reports for Patients with Chronic Lymphocytic Leukemia, Now Featuring IGHV Mutation Status
30 Sep 21
Health Care, Analyst Ratings, Press Releases
SEATTLE, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (NASDAQ:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical
Adaptive Biotechnologies Announces Grand Opening of State-of-the-Art Headquarters and Expands Footprint in Seattle
21 Sep 21
News, Press Releases
SEATTLE, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (NASDAQ:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical
Adaptive Biotechnologies to Present New SARS-CoV-2 Data from its Immune Medicine Platform During IDWeek 2021
16 Sep 21
News, Press Releases
SEATTLE, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (NASDAQ:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical
Adaptive Biotechnologies to Present at the Morgan Stanley Global Healthcare Conference
7 Sep 21
News, Press Releases
SEATTLE, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (NASDAQ:ADPT) a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical
Ultivue Announces New Independent Board Members
19 Aug 21
Press Releases
Ultivue announces the addition of two independent board members, Fenel Eloi and Mary Pat Lancelotta, to help strengthen its position as a leader in advancing precision medicine solutions by accelerating tissue biomarker
Curebase, Adaptive Biotechnologies Announce Collaboration to Expand Clinical Study Access
10 Aug 21
Press Releases
SAN FRANCISCO and SEATTLE, Aug. 10, 2021 /PRNewswire/ -- Curebase, a company committed to democratizing access to clinical studies, and Adaptive Biotechnologies Corp. (NASDAQ:ADPT), a biotechnology company that aims to
Adaptive Biotechnologies Appoints Nitin Sood as Chief Commercial Officer
4 Aug 21
News, Management, Press Releases
SEATTLE, Aug. 04, 2021 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (NASDAQ:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical
Adaptive Biotechnologies Reports Second Quarter 2021 Financial Results
4 Aug 21
Press Releases
SEATTLE, Aug. 04, 2021 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation ("Adaptive Biotechnologies") (NASDAQ:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive